Surgical Science Sweden AB (publ)

OM:SUS 株式レポート

時価総額:SEK 7.5b

Surgical Science Sweden マネジメント

マネジメント 基準チェック /34

Surgical Science Swedenの CEO はTom Englundで、 Oct2024年に任命され、 の在任期間は 1 年未満です。 の年間総報酬はSEK 1.67Mで、 82.9%給与と17.1%のボーナス(会社の株式とオプションを含む)で構成されています。 は、会社の株式の0.018%を直接所有しており、その価値はSEK 1.38M 。経営陣と取締役会の平均在任期間はそれぞれ4.3年と4年です。

主要情報

Tom Englund

最高経営責任者

SEK 1.7m

報酬総額

CEO給与比率82.94%
CEO在任期間less than a year
CEOの所有権0.02%
経営陣の平均在職期間4.3yrs
取締役会の平均在任期間4yrs

経営陣の近況

Recent updates

The Price Is Right For Surgical Science Sweden AB (publ) (STO:SUS) Even After Diving 27%

Mar 14
The Price Is Right For Surgical Science Sweden AB (publ) (STO:SUS) Even After Diving 27%

Surgical Science Sweden's (STO:SUS) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Mar 01
Surgical Science Sweden's (STO:SUS) Sluggish Earnings Might Be Just The Beginning Of Its Problems
author-image

Regulatory Approvals For New Robotics Entrants Will Drive Demand For Simulation Products

Jan 16 Strength in the Educational Products segment and rising demand for simulators indicate potential revenue growth and diversification opportunities.

The Price Is Right For Surgical Science Sweden AB (publ) (STO:SUS)

Nov 12
The Price Is Right For Surgical Science Sweden AB (publ) (STO:SUS)

Surgical Science Sweden AB (publ) Just Missed EPS By 22%: Here's What Analysts Think Will Happen Next

Aug 25
Surgical Science Sweden AB (publ) Just Missed EPS By 22%: Here's What Analysts Think Will Happen Next

Earnings Beat: Surgical Science Sweden AB (publ) Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Apr 21
Earnings Beat: Surgical Science Sweden AB (publ) Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Here's Why Surgical Science Sweden (STO:SUS) Has Caught The Eye Of Investors

Apr 16
Here's Why Surgical Science Sweden (STO:SUS) Has Caught The Eye Of Investors

Surgical Science Sweden AB (publ)'s (STO:SUS) Share Price Is Still Matching Investor Opinion Despite 25% Slump

Mar 17
Surgical Science Sweden AB (publ)'s (STO:SUS) Share Price Is Still Matching Investor Opinion Despite 25% Slump

Results: Surgical Science Sweden AB (publ) Beat Earnings Expectations And Analysts Now Have New Forecasts

Feb 24
Results: Surgical Science Sweden AB (publ) Beat Earnings Expectations And Analysts Now Have New Forecasts

Is There Now An Opportunity In Surgical Science Sweden AB (publ) (STO:SUS)?

Nov 29
Is There Now An Opportunity In Surgical Science Sweden AB (publ) (STO:SUS)?

Should You Be Adding Surgical Science Sweden (STO:SUS) To Your Watchlist Today?

Oct 07
Should You Be Adding Surgical Science Sweden (STO:SUS) To Your Watchlist Today?

Is Surgical Science Sweden AB (publ) (STO:SUS) Trading At A 39% Discount?

Aug 17
Is Surgical Science Sweden AB (publ) (STO:SUS) Trading At A 39% Discount?

With EPS Growth And More, Surgical Science Sweden (STO:SUS) Makes An Interesting Case

Jun 20
With EPS Growth And More, Surgical Science Sweden (STO:SUS) Makes An Interesting Case

A Look At The Fair Value Of Surgical Science Sweden AB (publ) (STO:SUS)

May 17
A Look At The Fair Value Of Surgical Science Sweden AB (publ) (STO:SUS)

Surgical Science Sweden AB (publ) (STO:SUS) Shares Could Be 49% Below Their Intrinsic Value Estimate

Dec 27
Surgical Science Sweden AB (publ) (STO:SUS) Shares Could Be 49% Below Their Intrinsic Value Estimate

Is Now The Time To Put Surgical Science Sweden (STO:SUS) On Your Watchlist?

Dec 06
Is Now The Time To Put Surgical Science Sweden (STO:SUS) On Your Watchlist?

Is Now The Time To Look At Buying Surgical Science Sweden AB (publ) (STO:SUS)?

Sep 08
Is Now The Time To Look At Buying Surgical Science Sweden AB (publ) (STO:SUS)?

We Ran A Stock Scan For Earnings Growth And Surgical Science Sweden (STO:SUS) Passed With Ease

Aug 23
We Ran A Stock Scan For Earnings Growth And Surgical Science Sweden (STO:SUS) Passed With Ease

Surgical Science Sweden AB (publ) (STO:SUS) Shares Slammed 33% But Getting In Cheap Might Be Difficult Regardless

May 26
Surgical Science Sweden AB (publ) (STO:SUS) Shares Slammed 33% But Getting In Cheap Might Be Difficult Regardless

Here's Why We Think Surgical Science Sweden (STO:SUS) Is Well Worth Watching

Apr 29
Here's Why We Think Surgical Science Sweden (STO:SUS) Is Well Worth Watching

An Intrinsic Calculation For Surgical Science Sweden AB (publ) (STO:SUS) Suggests It's 44% Undervalued

Feb 20
An Intrinsic Calculation For Surgical Science Sweden AB (publ) (STO:SUS) Suggests It's 44% Undervalued

Is It Too Late To Consider Buying Surgical Science Sweden AB (publ) (STO:SUS)?

Jan 11
Is It Too Late To Consider Buying Surgical Science Sweden AB (publ) (STO:SUS)?

Does Surgical Science Sweden (STO:SUS) Deserve A Spot On Your Watchlist?

Dec 15
Does Surgical Science Sweden (STO:SUS) Deserve A Spot On Your Watchlist?

Calculating The Intrinsic Value Of Surgical Science Sweden AB (publ) (STO:SUS)

Sep 16
Calculating The Intrinsic Value Of Surgical Science Sweden AB (publ) (STO:SUS)

Is It Too Late To Consider Buying Surgical Science Sweden AB (publ) (STO:SUS)?

Jul 05
Is It Too Late To Consider Buying Surgical Science Sweden AB (publ) (STO:SUS)?

Calculating The Fair Value Of Surgical Science Sweden AB (publ) (STO:SUS)

Jun 08
Calculating The Fair Value Of Surgical Science Sweden AB (publ) (STO:SUS)

Is It Too Late To Consider Buying Surgical Science Sweden AB (publ) (STO:SUS)?

Mar 23
Is It Too Late To Consider Buying Surgical Science Sweden AB (publ) (STO:SUS)?

Calculating The Intrinsic Value Of Surgical Science Sweden AB (publ) (STO:SUS)

Mar 02
Calculating The Intrinsic Value Of Surgical Science Sweden AB (publ) (STO:SUS)

Is Surgical Science Sweden AB (publ)'s (STO:SUS) Shareholder Ownership Skewed Towards Insiders?

Feb 09
Is Surgical Science Sweden AB (publ)'s (STO:SUS) Shareholder Ownership Skewed Towards Insiders?

CEO報酬分析

Surgical Science Sweden の収益と比較して、Tom Englund の報酬はどのように変化したか?
日付総報酬給与会社業績
Mar 31 2025n/an/a

SEK 141m

Dec 31 2024SEK 2mSEK 1m

SEK 132m

報酬と市場: Tomの 総報酬 ($USD 170.66K ) は、 Swedish市場 ($USD 754.35K ) の同様の規模の企業の平均を下回っています。

報酬と収益: Tomの報酬と会社の業績を比較するにはデータが不十分です。


CEO

Tom Englund (48 yo)

less than a year

在職期間

SEK 1,671,000

報酬

Mr. Tom Englund serves as Director at Intelligent Ultrasound Group plc since February 18, 2025. He is Chief Executive Officer of Surgical Science Sweden AB (publ) from October 1, 2024. He joined Surgical S...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Tom Englund
Chief Executive Officerless than a yearSEK 1.67m0.018%
SEK 1.4m
Anders Larsson
Co-Founder & CTO6.3yrsデータなしデータなし
Anna Ahlberg
Chief Financial Officer7.3yrsデータなし0.047%
SEK 3.5m
Boaz Tal
Chief Operating Officer4.3yrsデータなしデータなし
Adele Horn
IR Managerno dataデータなしデータなし
Martin Jansson
Head of Global Sales4.3yrsデータなしデータなし
Inbal Mazor-Badichi
Chief Product & Marketing Officer3.5yrsデータなし0.036%
SEK 2.7m
Daniel Evestedt
Head of Development5.5yrsデータなしデータなし
Jeffrey Berkley
Chief Innovation Officer4.3yrsデータなしデータなし
Doron Zilberman
Executive Vice President of International Sales & Educational Productsno dataデータなしデータなし
Niclas Olsson
Chief Revenue Officerless than a yearデータなし0.00098%
SEK 73.1k
Ariel Moshe
Chief R&D Officerless than a yearデータなし0.024%
SEK 1.8m

4.3yrs

平均在職期間

54yo

平均年齢

経験豊富な経営陣: SUSの経営陣は 経験豊富 であると考えられます ( 4.3年の平均在職年数)。


取締役

名称ポジション在職期間報酬所有権
Roland Bengtsson
Director20.3yrsデータなしデータなし
Jan Bengtsson
Director20.3yrsデータなし13.99%
SEK 1.0b
Gisli Hennermark
Chairman of the Boardless than a yearSEK 6.12m0.63%
SEK 47.1m
Thomas Eklund
Independent Director8.3yrsデータなし0.0027%
SEK 204.3k
Asa Bredin
Independent Director2yrsデータなし0.00069%
SEK 51.4k
Elisabeth Hansson
Independent Director4yrsデータなし0.0026%
SEK 190.1k
Henrik Falconer
Independent Director4yrsデータなし0.0020%
SEK 146.1k

4.0yrs

平均在職期間

52yo

平均年齢

経験豊富なボード: SUSの 取締役会経験豊富 であると考えられます ( 4年の平均在任期間)。


企業分析と財務データの現状

データ最終更新日(UTC時間)
企業分析2025/05/18 03:10
終値2025/05/16 00:00
収益2025/03/31
年間収益2024/12/31

データソース

企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。

パッケージデータタイムフレーム米国ソース例
会社財務10年
  • 損益計算書
  • キャッシュ・フロー計算書
  • 貸借対照表
アナリストのコンセンサス予想+プラス3年
  • 予想財務
  • アナリストの目標株価
市場価格30年
  • 株価
  • 配当、分割、措置
所有権10年
  • トップ株主
  • インサイダー取引
マネジメント10年
  • リーダーシップ・チーム
  • 取締役会
主な進展10年
  • 会社からのお知らせ

* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用

特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM(Trailing Twelve Month)またはLTM(Last Twelve Month)データとして知られています。詳細はこちら

分析モデルとスノーフレーク

このレポートの作成に使用した分析モデルの詳細は、Githubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeでのチュートリアルもご用意しています。

シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。

業界およびセクターの指標

私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。

アナリスト筋

Surgical Science Sweden AB (publ) 6 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。6

アナリスト機関
Simon JonssonBerenberg
Viktor HögbergDanske Bank
Jonatan AnderssonDNB Markets